Promise Tracker
0 delivered, 0 close, 2 missed.
View Promises →Happiest Minds delivered a strong Q1 FY26 with 17.5% YoY constant currency growth and EBITDA margin of 21.4%, well within the guided 20-22% range.
✓ Verified against BSE filing
Happiest Minds delivered a strong Q1 FY26 with 17.5% YoY constant currency growth and EBITDA margin of 21.4%, well within the guided 20-22% range. Revenue reached ₹580 crore, up 18.5% YoY, while EBITDA stood at ₹124 crore with 12.9% sequential growth. PAT grew 12% YoY to ₹57 crore. Growth was broad-based, led by GenAI (82% YoY), IMS, and verticals like BFSI and healthcare. Management reiterated double-digit growth guidance for FY26 and expects H2 to be stronger despite Q3 seasonality. Key risks include elevated attrition (18.2%), potential margin pressure from wage hikes in Q2, and macroeconomic uncertainty in the US market.
हैप्पिएस्ट माइंड्स ने वित्त वर्ष 2026 की पहली तिमाही में मजबूत प्रदर्शन किया। कंपनी की आय पिछले साल की तुलना में 17.5% बढ़ी, और मुनाफा (EBITDA) 21.4% रहा, जो उसके अनुमानित 20-22% के दायरे में है। कुल कमाई ₹580 करोड़ हुई, जो पिछले साल से 18.5% ज्यादा है। मुनाफा (PAT) ₹57 करोड़ रहा, जो 12% बढ़ा। कंपनी की ग्रोथ GenAI (82% बढ़ोतरी), IMS, और बैंकिंग-स्वास्थ्य जैसे क्षेत्रों से आई। प्रबंधन ने पूरे साल दो अंकों की ग्रोथ का अनुमान दोहराया। जोखिमों में कर्मचारियों का छोड़ना (18.2%), वेतन बढ़ने से मुनाफा दबाव, और अमेरिकी बाजार में अनिश्चितता शामिल है।
0 delivered, 0 close, 2 missed.
View Promises →US market softness and top client decline
View Risks →Full transcript text is available on this route.
Read Transcript →GenAI business unit grew 82% year-on-year and 12.7% sequentially, with utilization improving from 34.3% to 48.4%.
Active customers increased from 281 to 285, while million-dollar customers grew from 57 to 59.
Utilization reached a nine-quarter high of 78.9%, reflecting improved delivery efficiency and demand-aligned resourcing.
Attrition trended up to 18.2%, driven by high demand for digital and AI skills; management is implementing retention programs.
The GenAI business unit, which broke even at operating margin level in Q1, is expected to achieve profitability levels comparable to the TDES segment by year-end or early next year.
The flagship unified banking platform ARTA is expected to grow revenues by 20-25% in the current fiscal year.
Management expects to deliver double-digit growth in constant currency for the full fiscal year, with H2 expected to be stronger than H1.
EBITDA margin is guided to remain in the 20-22% range for FY26, despite wage hikes and continued investments.
Approximately 15 GenAI proof-of-concept projects are expected to convert into significant orders and projects in the next fiscal year.
US revenues saw a sequential decline due to completion of a large program and a customer pausing programs, raising concerns about near-term growth in the largest market.
Attrition rose to 18.2%, driven by high demand for digital and AI skills, which could pressure margins and require higher compensation adjustments.
Management flagged planned pay increases in Q2 as a cost headwind, which may compress margins unless offset by efficiency gains and currency benefits.
DSO increased to 91 days from 87 days, partly due to billing system integration with the Middle East entity acquired, which could impact cash flows if not resolved quickly.
EdTech revenue declined due to customer insourcing and platform completion; management expects the segment to remain slow.
GenAI business unit is in investment mode, with $1.5M spent in nine months; margins could be pressured if revenue ramp-up is slower than expected.
Attrition increased to 15.3% (seasonal), but if it persists, it could impact delivery and margins.
BFSI growth is strong, but over-reliance on one vertical could be a risk if sector spending slows.
Management expects to deliver double-digit growth in constant currency for the full fiscal year, with H2 expected to be stronger than H1.
US revenues saw a sequential decline due to completion of a large program and a customer pausing programs, raising concerns about near-term growth...
View Risks →